UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

The Journal of infectious diseases, 2015-04, Vol.211 (8), p.1279-1287

2015

Volltextzugriff (PDF)

Pulmonary nocardiosis in Western Europe—Clinical evaluation of 43 patients and population-based estimates of hospitalization rates

International journal of infectious diseases, 2019-04, Vol.81, p.140-148

2019

Volltextzugriff (PDF)

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4117-4123

2012

Volltextzugriff (PDF)

Macrophages Accumulate in the Gut Mucosa of Untreated HIV-infected Patients

The Journal of infectious diseases, 2014-03, Vol.209 (5), p.739-748

2014

Volltextzugriff (PDF)

Uncapped Metered-Dose Inhalers: A Risk for Foreign Body Aspiration. A Case Report and Review of the Literature

International journal of chronic obstructive pulmonary disease, 2023-09, Vol.18, p.1931-1935

2023

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals

AIDS (London), 2016-01, Vol.30 (1), p.57-63

2016

Volltextzugriff (PDF)

Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience

BMC pulmonary medicine, 2019-12, Vol.19 (1), p.232-232, Article 232

2019

Volltextzugriff (PDF)

Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects

The Journal of infectious diseases, 2012-10, Vol.206 (7), p.1002-1011

2012

Volltextzugriff (PDF)

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study

PloS one, 2014-05, Vol.9 (5), p.e95956-e95956

2014

Volltextzugriff (PDF)

Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study

HemaSphere, 2024-07, Vol.8 (7), p.e68-n/a

2024

Volltextzugriff (PDF)

Clonal expansion of CD4 + CD8 + T cells in an adult patient with Mycoplasma pneumoniae-associated Erythema multiforme majus

Allergy, asthma, and clinical immunology, 2021-02, Vol.17 (1), p.17-17, Article 17

2021

Volltextzugriff (PDF)

Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.1245-1259

2016

Volltextzugriff (PDF)

High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery

ERJ open research, 2021-04, Vol.7 (2), p.60

2021

Volltextzugriff (PDF)

Treatment with Sequential Intravenous or Oral Moxifloxacin Was Associated with Faster Clinical Improvement than Was Standard Therapy for Hospitalized Patients with Community-Acquired Pneumonia Who Received Initial Parenteral Therapy

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1697-1705

2005

Volltextzugriff (PDF)

Ocular syphilis – indicator of previously unknown HIV-infection

The Journal of infection, 2009-01, Vol.58 (1), p.32-36

2009

Volltextzugriff (PDF)

Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered over 21 Days with Lopinavir-Ritonavir in Human Immunodeficiency Virus Type 1-Infected Subjects

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.662-669

2009

Volltextzugriff (PDF)

Monkeypox in-patients with severe anal pain

Infection, 2023-04, Vol.51 (2), p.483-487

2023

Volltextzugriff (PDF)

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

The Lancet infectious diseases, 2014-04, Vol.14 (4), p.291-300

2014

Volltextzugriff (PDF)

O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days

Journal of Virus Eradication, 2017-09, Vol.3, p.2

2017

Volltextzugriff (PDF)

Mycobacterium tuberculosis -specific CD4 T-cell scoring discriminates tuberculosis infection from disease

The European respiratory journal, 2022-07, Vol.60 (1)

2022

Volltextzugriff (PDF)

M ycobacterium tuberculosis -specific CD4 T-cell scoring discriminates tuberculosis infection from disease

The European respiratory journal, 2022-07, Vol.60 (1), p.2101780

2022

Volltextzugriff (PDF)

Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-arm follow-on study

Clinical therapeutics, 2006-05, Vol.28 (5), p.745-754

2006

Volltextzugriff (PDF)

P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days

Journal of Virus Eradication, 2016-09, Vol.2, p.4-4

2016

Volltextzugriff (PDF)

A time-resolved proteomic and prognostic map of COVID-19

Cell systems, 2021-08, Vol.12 (8), p.780-794.e7

2021

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Englisch
(168)
Deutsch
(7)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

Pulmonary nocardiosis in Western Europe—Clinical evaluation of 43 patients and population-based estimates of hospitalization rates

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

Macrophages Accumulate in the Gut Mucosa of Untreated HIV-infected Patients

Uncapped Metered-Dose Inhalers: A Risk for Foreign Body Aspiration. A Case Report and Review of the Literature

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals

Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience

Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study

Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study

Clonal expansion of CD4 + CD8 + T cells in an adult patient with Mycoplasma pneumoniae-associated Erythema multiforme majus

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy

High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery

Treatment with Sequential Intravenous or Oral Moxifloxacin Was Associated with Faster Clinical Improvement than Was Standard Therapy for Hospitalized Patients with Community-Acquired Pneumonia Who Received Initial Parenteral Therapy

Ocular syphilis – indicator of previously unknown HIV-infection

Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered over 21 Days with Lopinavir-Ritonavir in Human Immunodeficiency Virus Type 1-Infected Subjects

Monkeypox in-patients with severe anal pain

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days

Mycobacterium tuberculosis -specific CD4 T-cell scoring discriminates tuberculosis infection from disease

M ycobacterium tuberculosis -specific CD4 T-cell scoring discriminates tuberculosis infection from disease

Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-arm follow-on study

P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days

A time-resolved proteomic and prognostic map of COVID-19

Suchergebnisse filtern